Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
European Journal of Pharmacology
|
December 31, 2002
Agonist-specific down-regulation of the human delta-opioid receptor
Takashi Okura, Eva V Varga, Yoshiaki Hosohata, et al.
Cellular and Molecular Neurobiology
|
February 29, 2020
Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents
Caroline M Kopruszinski, Juliana Swiokla, Yeon Sun Lee, et al.
Brain : a Journal of Neurology
|
March 24, 2022
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine
Moe Watanabe, Caroline M Kopruszinski, Aubin Moutal, et al.
Pain
|
April 10, 2012
Contribution of PKMζ-dependent and independent amplification to components of experimental neuropathic pain
Tamara King, Chaoling Qu, Alec Okun, et al.
Cephalalgia : an International Journal of Headache
|
May 13, 2022
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache
Edita Navratilova, Janice Oyarzo, Trent Anderson, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2015
Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities
Padma Nair, Takashi Yamamoto, Scott Cowell, et al.
Cephalalgia : an International Journal of Headache
|
November 2, 2020
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine
Caroline M Kopruszinski, Peter Thornton, Joanne Arnold, et al.
Pain
|
August 23, 2016
Hedonic and motivational responses to food reward are unchanged in rats with neuropathic pain
Alec Okun, David L McKinzie, Jeffrey M Witkin, et al.
Journal of Medicinal Chemistry
|
May 23, 2007
Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists
Takashi Yamamoto, Padma Nair, Peg Davis, et al.
The Journal of Headache and Pain
|
October 16, 2025
OnabotulinumtoxinA inhibits dysregulation of descending pain modulation following mild traumatic brain injury in mice
Robson C Lillo Vizin, Caroline M Kopruszinski, Janice N Oyarzo, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
European Journal of Pharmacology
|
December 31, 2002
Agonist-specific down-regulation of the human delta-opioid receptor
Takashi Okura, Eva V Varga, Yoshiaki Hosohata, et al.
Cellular and Molecular Neurobiology
|
February 29, 2020
Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents
Caroline M Kopruszinski, Juliana Swiokla, Yeon Sun Lee, et al.
Brain : a Journal of Neurology
|
March 24, 2022
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine
Moe Watanabe, Caroline M Kopruszinski, Aubin Moutal, et al.
Pain
|
April 10, 2012
Contribution of PKMζ-dependent and independent amplification to components of experimental neuropathic pain
Tamara King, Chaoling Qu, Alec Okun, et al.
Cephalalgia : an International Journal of Headache
|
May 13, 2022
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache
Edita Navratilova, Janice Oyarzo, Trent Anderson, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2015
Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities
Padma Nair, Takashi Yamamoto, Scott Cowell, et al.
Cephalalgia : an International Journal of Headache
|
November 2, 2020
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine
Caroline M Kopruszinski, Peter Thornton, Joanne Arnold, et al.
Pain
|
August 23, 2016
Hedonic and motivational responses to food reward are unchanged in rats with neuropathic pain
Alec Okun, David L McKinzie, Jeffrey M Witkin, et al.
Journal of Medicinal Chemistry
|
May 23, 2007
Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists
Takashi Yamamoto, Padma Nair, Peg Davis, et al.
The Journal of Headache and Pain
|
October 16, 2025
OnabotulinumtoxinA inhibits dysregulation of descending pain modulation following mild traumatic brain injury in mice
Robson C Lillo Vizin, Caroline M Kopruszinski, Janice N Oyarzo, et al.
Page
of 11